Product Program year 2023 Source: CMS Open Payments

Uribel

Drug Analgesic Antispasmodic & Antiseptic (Urinary)

NDC 0178-0740-01

Open in the dashboard

General payments

$7,488

455 payments

Research payments

$0

0 payments

Through program year 2023, $7,488 in general payments and $0 in research payments were reported against Uribel (Analgesic Antispasmodic & Antiseptic (Urinary)).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2023 General $7,488 455

Breakdown

Who paid General payments · program year 2023
  1. Mission Pharmacal Company $7,488 455 payments
Top recipients General payments · program year 2023
  1. Sujata Yavagal Urogynecology and Reconstructive Pelvic Surgery · Miami, FL $162 2% · 8 payments
  2. Jorge Pimienta Miami, FL $136 2% · 8 payments
  3. Thara Bhangu Physician Assistant, Medical · Miami, FL $107 1% · 5 payments
  4. Christina Freile Physician Assistant, Surgical · Raleigh, NC $105 1% · 6 payments
  5. Michael Tyler Urology · Coral Springs, FL $104 1% · 7 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2023.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2023
  1. Urology $3,736 52% · 161 practitioners
  2. Physician Assistant $810 11% · 35 practitioners
  3. Nurse Practitioner, Family Nurse Practitioner $664 9% · 30 practitioners
  4. Nurse Practitioner $571 8% · 26 practitioners
  5. Urogynecology and Reconstructive Pelvic Surgery Obstetrics & Gynecology $458 6% · 10 practitioners

The top 5 of 18 specialties; each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2023
  1. Florida $1,715 23% · 37 recipients
  2. Pennsylvania $1,143 15% · 45 recipients
  3. North Carolina $885 12% · 27 recipients
  4. Illinois $689 9% · 39 recipients
  5. Massachusetts $387 5% · 16 recipients

The top 5 of 25 states; each share is of general payments naming this product in 2023 where a state was reported.

The top 25 states, free in the app

455 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record